HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Pixantrone

HCID 134019
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
144510-96-3
Standard SMILES
NCCNc1ccc(NCCN)c2c1C(=O)c1ccncc1C2=O
InChIKey
PEZPMAYDXJQYRV-UHFFFAOYSA-N
Molecular formula
C17H19N5O2
Average molar mass
325.4 g/mol
Monoisotopic mass
325.15387485

Overview

Pixantrone is a member of isoquinolines.

Names & identifiers

Preferred name
Pixantrone
IUPAC
6,9-bis(2-aminoethylamino)benzo[g]isoquinoline-5,10-dione
English name
Pixantrone
Molecular formula
C17H19N5O2
Molecular weight
325.37

Names & synonyms

Pixantrone144510-96-36,9-bis(2-aminoethylamino)benzo[g]isoquinoline-5,10-dione6,9-Aea-biqdoPixantronaF5SXN2KNMRBBR-27786,9-bis((2-aminoethyl)amino)benzo[g]isoquinoline-5,10-dioneBBR27786,9-Bis((2-aminoethyl)amino)benzo(g)isoquinoline-5,10-dione6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dioneBenz[g]isoquinoline-5,10-dione, 6,9-bis[(2-aminoethyl)amino]-
Show more names
CS-1359Pixantrone, BBR 2778BBR 2778Pixantrone diformate salt6,9-Bis[(2-aminoethyl)amino]benz[g]isoquinoline-5,10-dione
DTXSID101627445,8-Bis((2-aminoethyl)amino)-2-aza-anthracene-9,10-dioneBenz(g)isoquinoline-5,10-dione, 6,9-bis((2-aminoethyl)amino)-pixantronum6,9-bis(2-aminoethylamino)benzo(g)isoquinoline-5,10-dioneRefChem:929364DTXCID1085235SID225144373

Database identifiers

CAS
144510-96-3、144675-97-8
PubChem CID
134019

Properties

Computed structural properties

XLogP
1
Topological polar surface area
123 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
7
Rotatable bonds
6
Heavy atoms
24
Formal charge
0
Complexity
472

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15

Physicochemical properties

Melting point
173 °C · >173°C (dec.)
Boiling point
650 · 650.0±55.0 °C(Predicted)
Density
1.405 · 1.405
storage temp.
Refrigerator
solubility
DMSO (Slightly), Methanol (Slightly)
form
Solid
pka
9.34 · 9.34±0.10(Predicted)
color
Dark Blue to Very Dark Blue
NCI Dictionary of Cancer Terms
pixantrone
FDA UNII
5 SXN2KNMR · F5SXN2KNMR
NCI Drug Dictionary
pixantrone dimaleate
ATC code
1 DB11 · L01DB11
Comptox DTXSID

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H300 (50%): Fatal if swallowed [Danger Acute toxicity, oral]

P203, P260, P262, P264, P270, P271, P280, P284, P301+P316, P302+P352, P304+P340, P308+P316, P316, P318, P320, P321, P330, P361+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 2 (50%)

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P305+P351+P338

Chemistry & industry

Pharmacology

ATC Code · 2 items

L - Antineoplastic and immunomodulating agents

QL - Antineoplastic and immunomodulating agents

Protein BindingAnthracyclines, which may be effective second line treatments for NHL have limited use in therapy because of cumulative cardiotoxicity which may result in irreversible damage to cardiac tissue. [2]
Pharmacodynamics · 1 item

Pixantrone has a wide range of antitumor activity, especially in terms of treating leukemias and lymphomas [3]. Pixantrone lacks cardio-toxic effects. It has postulated that his is because of its redox inactivity and lack and inhibition of doxorubicinol formation in human myocardium. [3]

Mechanism of Action · 1 item

Pixantrone is an aza-anthracenedione which acts as a DNA intercalator. By intercalating between DNA, with modest affinity, it stimulates DNA cleavage by topoisomerase II. (Pixantrone acts as a poison to topoisomerase II by stabilizing protein-DNA complexes which are usually transient, giving rise to double stranded DNA breaks.) However, pixantrone is believed to have additional mechanisms of action as its potency does not correlate to the degree of double stranded DNA breaks observed. It has been postulated that this second mechanism may be pixantrone-DNA adduct formation. [1] It is important to note that the formation of a pixtantrone-DNA adduct requires pixantrone activation by formaldehyde. Formadehyde may be generated in vitro by hydrogen peroxide, and is derived by various sources in biological systems. It is present in low levels as a result of normal metabolism, and may be present in elevated levels in some haematolgical malignancies. [1] The formation of pixantrone-DNA adducts is thus feasible, and it is believed that a long pixantrone-DNA adduct half life has the potential to maximize DNA damage. It may do so by enhancing the disruption of DNA replication and transcription, and potentially by encourage apoptosis. [1] In explanation of pixantrones lack of cardiotoxicity, it has been elucidated that pixantrone is structurally similar to mitoxantrone; however, instead of a 5,8-dihydroxyphenyl ring (thought to be responsible for cardiotoxicity) it has a nitrogen heteroatom. This nitrogen heteroatom helps to create additional hydrogen bonding sites amd increases pixantrone interaction with DNA and topoisomerase II. [2] Pixantrone's lack of a hydroquinone is believed to render it resistant to one electron reduction. In contrast, doxorubicin - which contains a hydroquinone - experiences one electron redox cycling and ROS formation via NADH dehydrogenase. [3] Pixantrone also does not bind iron, and thus does not produce ROS by redox cycling between oxidative states of iron, as other anthracyclines do. [2] The first line agent doxorubicin is cardiotoxic, in part, due to its ability to redox activate the superoxide anion and hydrogen peroxide, and form a long-lived secondary alcohol metabolite: doxorubicinol. [3] Clearance of doxorubicin from myocardial tissue is incomplete, and it can be found months or years after the last administration. [3] In doxorubicin treated ex vivo cardiac strips, pixantrone formed an N-dealkylated product that inhibited metabolism of residual doxorubicin into doxorubicinol. Additionally, in ex vivo human myocardial strips (doxorubicin naive, and doxorubicin pretreated) pixantrone showed high cardiac uptake without formation of superoxide anion or hydrogen peroxide. Pixantrones lack of cardiotoxicity is thus attributed to its redox inactivity and inhibition of doxorubicinol formation. [3]

Related reactions

8 records
New reaction record
HRID 52402 reaction equation
HRID 52402As product
HRID 269708 reaction equation
HRID 269708As reactant
HRID 862158 reaction equation
HRID 862158As product
HRID 862162 reaction equation
HRID 862162As product
HRID 862163 reaction equation
HRID 862163As product
HRID 862164 reaction equation
HRID 862164As reactant
HRID 1720233 reaction equation
HRID 1720233As product
HRID 1720236 reaction equation
HRID 1720236As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
DTXSID
DTXSID10162744
ChEMBL
CHEMBL167731
ChEBI
CHEBI:135945
UNII
F5SXN2KNMR
EC Number
680-661-5
Nikkaji
J580.321G
10162744 · DTXSID10162744
Protein binding
50 % · 50%
Excreted unchanged in urine
10 % · <10%
Volume of distribution
9.7 · 9.7-29.7(L/kg)
Biological half-life
14.5 · 14.5-44.8
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P305+P351+P338
Biological Half-LifeHalf life ranges from 14.7 to 31.9 hours.
Metabolism/Metabolites · 1 item

Pixantrone does not form secondary alcohol metabolites. [2] Pixantrone hydrolyzes extensively to CT-45886 which is believed to inhibit doxol formation by displacing DOX from the active site of reductases. CT4889 and CT-45890 are also formed.[3]

MeSH Pharmacological Classification · 1 item

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.

Absorption, Distribution and Excretion · 4 items

Intravenous administration results in a rapid distribution followed by a slow elimination. [2] In ex vivo myocardial strips, pixantrone is taken up to a higher degree than mitoxantrone. In myocardial strips which are doxorubicin naive pixantrone displays higher uptake than in DOX-loaded myocardial strips. DOX clearance causes membrane effects which may be responsible for this observation. DOX clearance involves rapid passive diffusion through one side of the membrane followed by "flip flop" reorientation of the lipid bilayer. This disorganization of lipids is believed to impair membrane penetration by pixantrone. [3]

Fecally and renally excreted. Urinary elimination of unchanged drug is less than 10%. [2]

9.7-29.7 L/kg. [2]

Plasma clearance is 0.75 - 1.31 L/h/kg. [2]

Applications · 3 items

DescriptionIn May 2012, pixantrone was approved by the European Commission as a single agent for the treatment of relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (NHL) in adult patients who have failed on at least two previous therapies. Pixantrone (also known as BBR- 2778) is an anthracycline analogue that was specifically designed to address the cardiotoxicity seen in earlier agents by replacement of a 1,4- dihydroxyanthracene-9,10-dione core with a benzoisoquinoline-5,10-dione ring system. Pixantrone inhibits topoisomerase II by intercalation with DNA and is also believed to form covalent adducts with the N-2 amino group of guanine via a formaldehyde aminal formed with the primary amino groups. Pixantrone is less cytotoxic than other anthracycline derivatives, but shows good antitumor activity in vivo in a variety of preclinical tumor models, including leukemia and lymphoma models. Pixantrone also demonstrated significantly reduced cardiotoxicity in preclinical models compared with the anthracyclines doxorubicin and mitroxantrone. Pixantrone was synthesized by Friedel–Crafts reaction of pyridine-3,4-dicarboxylic acid anhydride with 1,4-difluorobenzene to give a ketoacid that was cyclized to the tricyclic core by treatment with fuming sulfuric acid at 140℃. Reaction of the resulting 6,9-difluorobenzoisoquinoline-5-10-dione with ethylenediamine followed by careful pH adjustment and treatment with maleic acid gave pixantrone in good overall yield and purity.

UsesPixantrone is an antineoplastic drug belonging to group of antitumor antibiotics. Pixantrone is an anlogue of Mitoxantrone (M373425) and is just as potent in the treatment of multiple sclerosis with fewer toxic effects on cardiac tissue. Studies suggest that Pixantrone significantly reduces amyloid beta (A beta(1-42)) neurotoxicity, a mechanism implicated in Alzheimer's disease.

Usesanti-inflammatory and immunosuppressive glucocorticoid steroid

Upstream & downstream products

Upstream raw materials

Benz[g]isoquinoline-5,10-dione, 6,9-dihydroxy-isoquinoline-5,10-dione">6,9-difluorobenzoisoquinoline-5,10-dionePyridine-3,4-dicarboxylic anhydrideEthylenediamine3,4-Pyridinedicarboxylic acid

Additional notes

DefinitionChEBI: Pixantrone is a member of isoquinolines.